BERLIN--Ribozyme Pharmaceuticals of Boulder, Colo., has formed a new company here with help from private sector investments and funding commitments from the German government as part of the government's initiative to encourage new biotechnology investments in the country. The investments could provide in excess of $50 million for five years.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.